Default Mode Network Modulation by Psychedelics: A Systematic Review

Cited by (255)

Items 201–255 of 255

1. Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD
   Sarah Shnayder, Gabrielle Agin-Liebes, Troy Hubert, Terence H. W. Ching, Jamila Hokanson, Christopher Pittenger, Benjamin Kelmendi, Thomas G. Adams · 2026 · Frontiers in Psychiatry
2. Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review
   L. Magnani, Luca Ghirotto, Fabio Fesce, Tania Simona Re, Silvia Tanzi, Andrea Amerio, Alessandra Costanza · 2026 · BMJ Supportive & Palliative Care
3. Psychedelics; an untapped therapeutic niche: a narrative review in the future of cancer pain management
   Maxine Min Chien Yap, Yasir Marwan Abdalla Omer, Yu Xuan Cheng, Wei Qi Chan, Satoshi Ogawa · 2026 · Medicine in Drug Discovery
4. Holding space between notes: Music, silence, and cultural attunement in psychedelic-assisted therapy
   Dalia N. Balsamo, Prachi Garodia, Nima Fayazmanesh, Austin K. Nguy · 2026 · Psychedelics
5. Dreamliminal: A Closed-Loop EEG Wearable for Prolonging the N1 Sleep Stage
   Xiao Zoe Fang, Tian Zhou, Duoduo Li, Michaela Jayne Vranic-Peters, Nathan Arthur Semertzidis, Yanming Zhu, Jiajun Bu, Adam Haar Horowitz, Pattie Maes, Nathan W. Whitmore · 2026 · CHI Conference Extended Abstracts on Human Factors in Computing Systems (CHI EA)
6. Brain Changes Underlying Irritable Bowel Syndrome Symptom Improvement in Response to Mindfulness‐Based Stress Reduction
   Jennifer S. Labus, Guistinna Tun, Paul W. Savoca, Desiree R. Delgadillo, Kevin M. Antony, Cathy Liu, Suzanne R. Smith, J. Greg Serpa, Jean Stains, Bruce D. Naliboff et al. · 2026 · Neurogastroenterology & Motility
7. Resetting the default in the psychedelic renaissance
   Sujit T. Thomas · 2026 · BioSocieties
8. Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects
   Zhen Xuen Brandon Low · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
9. Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression – A Systematic Review
   Brayan Jonas Mano‐Sousa, Maria Clara Gama Fontes, Ana Anacleto Gonçalves, José Carlos Fernandes Galduróz, Joaquim Maurício Duarte‐Almeida · 2026 · Journal of Psychoactive Drugs
10. The Neuropharmacology of Psychedelics
    Denis Pavăl · 2026 · SpringerBriefs in religious studies
11. Depression in Autism Spectrum Disorder: Neurobiological Convergence and Emerging Therapeutic Strategies
    Seham M. Al Raish, Mustafa M Shokr, Reem M Eladawy, Yasmena O. Azar · 2026 · Biology
12. Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats
    Noah J. Cavallaro, Priya Rai, David Akins, Sima Soltanpour, Md Taufiq Nasseef, Richard J. Ortiz, Rachel Utama, Caitlyn R. Cody, Anoushka Mistry, Heather C. Brenhouse et al. · 2026 · Neuroscience Bulletin
13. Reframing distress in oncology: the potential of psychedelic-assisted therapy
    Fatima Zohra Moujahid, Olivier Taymans · 2026 · Current Opinion in Oncology
14. Antidepressant effect of psychedelic compounds and mechanisms underlying the G protein-coupled receptors activation psychedelics: Antidepressant action and GPCR signaling
    Amanda Gollo Bertollo, Vinícius Alexandre Wippel, Maiqueli Eduarda Dama Mingoti, Rui Daniel Prediger, Zuleide Maria Ignácio · 2026 · European Journal of Pharmacology
15. A hierarchical multi-scale framework for schizophrenia: integrating symptom networks, functional circuits, and molecular pathways
    Peng Cheng, Zhening Liu, Xue Li, Feiwen Wang, Xingang Chen, Wenqiang Li, Chuansheng Wang, Yuchao Jiang, Jianfeng Feng, Yongfeng Yang et al. · 2026 · Molecular Psychiatry
16. Insight to Action: The Role of Occupational Therapy in Psychedelic Integration
    Gal Elkaiam, Heather Thomas, Brett Buford · 2026 · Occupational Therapy in Mental Health
17. Gehirn und Stille: neuronale Grundlagen innerer Regulation
    Thomas Herdin · 2026 · Innovativ und kompakt - gesellschaftliche Herausforderungen der Gegenwart
18. Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice
    Adam Robert Pines, Xue Zhang, John Kochalka, Sam S. Vesuna, Isaac Kauvar, Divya Rajasekharan, Travis R. Reneau, Teddy J. Akiki, Laura M. Hack, Joshua S. Siegel et al. · 2026 · Proceedings of the National Academy of Sciences
19. EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changes
    Nikola Jajcay, Čestmír Vejmola, Jakub Korčák, Filip Tylš, Michaela Viktorinová, Vojtěch Viktorin, Anna Bravermanová, Renata Androvičová, Balíková, Marie,, Jiřı́ Horáček et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
20. Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction
    Nadav Liam Modlin, Zsofia Elek, Carolina Maggio, Manish Agrawal, Lauren Lepow, James Rucker, Joanne Stubley, Jeffrey R. Guss · 2026 · Psychodynamic Psychiatry
21. Mystical States & Psilocybin. From Dissociation Towards Association: A Conversational Model Discussion
    Toby A. Clark · 2025 · The Therapeutic Conversation
22. THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY
    Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj · 2026 · International Journal of Innovative Technologies in Social Science
23. Decoding the serotonin–alcohol crosstalk: the role of central serotonergic dysregulation in alcohol use disorder
    Magdalena Zaniewska · 2026 · Pharmacological Reports
24. Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges
    Júlio César Claudino dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva, Germano Lapa Viana, Eduardo Pacheco Rico, Cinara Ludvig Gonçalves · 2026 · Journal of Psychiatric Research
25. Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations
    Cielo Amelia Estela-Fernandez, Reem Mohamed Yousif Elsheikh, D F Beatrice, Abdullah A. Alhendal, Chinonso Irene Ewe, Sebastian Y. Montesinos, Jocelyn Wensel, Anushka P Mishra, Asma Ahmed Yousif, Hossam Tharwat Ali · 2026 · Neuropsychiatrie
26. Structural determinants of dynamical state transitions in disorders of consciousness: a whole-brain modeling approach
    Fernando Lehue, Iván Mindlin, Carlos Coronel‐Oliveros, Enzo Tagliazucchi, Patricio Orio, Jacobo Diego Sitt · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
27. Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions
    Elena Koning, Jérémie Richard, Aaron R. Keshen · 2026 · International Journal of Eating Disorders
28. Combined DMT–harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers
    Helena Aicher, Joëlle Dornbierer, Luzia Caflisch, Dila Suay, Michael J. Mueller, Hans‐Peter Landolt, Boris B. Quednow, Milan Scheidegger, Dario Dornbierer · 2026 · Psychopharmacology
29. The experiential self-state as affective salience: a dual-self states framework for consciousness and self-transcendence
    Valerie van Mulukom · 2026 · Neuroscience of Consciousness
30. Mechanisms of Action and Change in Psychedelic-Assisted Therapies: A Holistic Framework for Ethical, Competent Clinical Care
    Lynnette A. Averill, Logan Neitzke‐Spruill · 2026 · FOCUS The Journal of Lifelong Learning in Psychiatry
31. Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
    Kristjan Kaup, Javier Hidalgo Jiménez, Jaan Aru · 2026 · Neuroscience & Biobehavioral Reviews
32. Consommation illicite de psychédéliques classiques et suicidalité : une revue systématique de la littérature
    Ana Beatriz Pereira de Oliveira, Matthieu Hein · 2026 · L Encéphale
33. Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation
    Hongyu Chen, Bowen Ke, Ruotian Jiang · 2026 · Molecules
34. Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics
    Gregory H. Jones, Jessica R. Gilbert, Jenessa N. Johnston, Nirmala Akula, Anton Schulmann, Miranda H. Arakelian, Shiyong Peng, Peixiong Yuan, Ewurakua A. Winful, Mani Yavi et al. · 2026 · Molecular Psychiatry
35. Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model
    Christopher P. Albertyn, Jérémie Richard, Ron Shore, Linda E. Carlson · 2026 · Psychedelics
36. How high ventilation breathwork alters consciousness: Hypoperfusion, network dynamics, and subjective experience
    Christian Nikolaus Schmitz, Marijan Bernardic, Anamaria-Domnica Vlădoiu, Rida Harris, Daniele Carmana, Laura Kärtner, Gunilla Oberthür, Gerhard Gründer, Hana Adolphi · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
37. Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy
    Mathieu Seynaeve, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, James Rucker, Anthony James Cleare, John Marsden · 2026 · Addiction
38. Neurobiologie der Psychedelika
    Christian Schmitz, Hana Adolphi · 2026 · Elsevier eBooks
39. Feasibility and tolerability of psilocybin for phantom limb pain
    Jon G. Dean, Ethan S. Hurwitz, Timothy J. Furnish, Joel P Castellanos, Arwynn McKinty, Briana Farrell, Daniel Barrows, Stephanie Knatz Peck, Julie Trim, Elowyn Samadhi et al. · 2026 · Journal of Pain
40. Perspectives on Meditation-based Preparation for Psychedelic Experiences: Insights from Practitioners with Combined Meditation and Psychedelic Experience
    Rosalind G. McAlpine, Merve Utanğaç, Joanna Kuc, Henok Pankhurst, Amelia Sellers, Doug Kraft, Andrew Litchy, Naina E. Gupta, Christopher Timmermann, Sunjeev K. Kamboj et al. · 2026 · Mindfulness
41. Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders
    Kathryn Fletcher, Jack Freestone, Nadine Ezard, Elizabeth Knock, Krista J. Siefried · 2026 · Current Addiction Reports
42. Psilocybin as an emerging anxiolytic: mechanisms, evidence, and open questions
    Gerasimos Konstantinou, Stefan M. Kloiber · 2026 · Neuropsychopharmacology
43. Ketamine-Assisted Intensive Short-Term Dynamic Psychotherapy
    Allen Kalpin · 2026 · Psychoanalytic Inquiry
44. Toward an interdisciplinary mind science of advanced meditation
    Jonathan M. Lieberman, Matthew D. Sacchet · 2026 · Trends in Cognitive Sciences
45. Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study
    Anna Kristina Eigenbrodt, Poul Pedersen Laigaard, Melika Hassani, Marwan Othman, Moshgan Amiri, Kirsten Møller, Jesper Kjærgaard, Daniel Kondziella · 2026 · BMJ Open
46. Psychedelics Restructure the Global Workspace of Consciousness
    Parsa Yousefi, Kenneth Shinozuka, Patrick Vizeli, Friederike Holze, A. Becker, Felix Müller, Matthias E. Liechti, Gregor Hasler, Carolyn I. Rodríguez, Andrea I. Luppi et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
47. Spiral brain dynamics track the temporal unfolding of subjective intensity during the N,N -dimethyltryptamine experience
    Gabriela Sawicka, Marian Martínez-Marín, Christopher Timmermann, Robin Lester Carhart-Harris, Morten L. Kringelbach, Yonatan Sanz Perl, Jakub Vohryzek, Gustavo Deco · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
48. Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics
    Xiubo Du, Feiyuan Peng, Xiaohui Wang · 2026 · Molecular Psychiatry
49. Operationalizing Excellence in Psychedelic Care Through Advancing Competencies in Nurses: State-of-the Science Review
    JoEllen Schimmels, Madison Nobbs · 2026 · Issues in Mental Health Nursing
50. Dose-dependent modulation of visual imagery by Ayahuasca and dampening of visual processing away from external input: a placebo-controlled pharmacoimaging study
    Miguel S. Castelo-Branco, Anna Gaidosch, Marta Teixeira, Gisela Lima, Carla Soares, Marta Lapo Pais, Patrícia Mendonca Rijo, Célia Cabral, Rainer Goebel · 2026 · Research Square
51. Decolonizing Psychedelic Art Therapy: Indigenous Plant Medicines, Creative Healing, and Epistemic Justice
    Uzma Shafi · 2026 · Art Therapy
52. From Altered States to Fundamental Peace: Taxonomies of Consciousness, Psychedelics and Hypnosis Through the Lens of the Yoga Vāsiṣṭha
    Luis Miguel Gallardo · 2026 · Journal of Happytalism and Fundamental Peace
53. Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence
    Erica S. Kaczmarek, Sabrina Wong, Noah Chisamore, Maya A. Stern, Zoe Doyle, Danica E. Johnson, Roger S. McIntyre, Joshua Daniel Rosenblat · 2026 · Journal of Psychiatric Research
54. Dissociating Resting-State Networks of Pedohebephilic Preference and Child Sexual Offending Using Network-Based Prediction
    Emin Serin, Kainat Raza Khan, Tillmann H.C. Krueger, Christopher Sinke, Klaus Michael Beier, Martin Walter, Boris Schiffer, Till Randolf Amelung, Henrik Walter · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
55. Evolutionary neuropharmacology of serotonergic psychedelics: a cross-species perspective on mechanisms, consciousness, and therapeutic potential.
    Hao-Jiang Zhai, Hong-Shuang Wang, Yi-Bo Wang, Xiao-Hui Wang · 2026 · Molecular Psychiatry